Jingyu Hou

机构：Hebei Medical University, Second Hospital of Hebei Medical University, Guangdong Academy of Medical Sciences · ORCID：0000-0001-7000-1808

发表论文 34 篇 · 总被引 317 次 · h-index 11

代表论文

Tenofovir vs. entecavir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative resection (2022 · Journal of Gastroenterology · 被引 39)
Radiomics-based model using gadoxetic acid disodium-enhanced MR images: associations with recurrence-free survival of patients with hepatocellular carcinoma treated by surgical resection (2021 · Abdominal Radiology · 被引 31)
Development and Validation of a Prognostic Score for Hepatocellular Carcinoma Patients in Immune Checkpoint Inhibitors Therapies: The Hepatocellular Carcinoma Modified Gustave Roussy Immune Score (2022 · Frontiers in Pharmacology · 被引 25)
Radiomics Model Based on Gadoxetic Acid Disodium-Enhanced MR Imaging to Predict Hepatocellular Carcinoma Recurrence After Curative Ablation (2021 · Cancer Management and Research · 被引 22)
Peptide hormone ELABELA promotes rat bone marrow-derived mesenchymal stem cell proliferation and migration by manipulating the cell cycle through the PI3K/AKT pathway under the hypoxia and ischemia microenvironment (2022 · Stem Cell Research & Therapy · 被引 20)
Levels of pretreatment serum lipids predict responses to PD-1 inhibitor treatment in advanced intrahepatic cholangiocarcinoma (2023 · International Immunopharmacology · 被引 17)